Overview Annovera™ Drug-Drug Interaction Study Status: Completed Trial end date: 2021-01-06 Target enrollment: Participant gender: Summary A Drug-Drug Interaction (DDI) study to evaluate the effects of itraconazole and rifampin on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol from the Annovera Contraceptive Vaginal System (CVS) Phase: Phase 1 Details Lead Sponsor: TherapeuticsMDTreatments: EstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEthinyl EstradiolHydroxyitraconazoleItraconazolePolyestradiol phosphateRifampinST 1435